| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.851 | 51.555 | 47.347 | 28.239 | 75.711 | 272.958 | 409.775 | 125.685 | 34.915 |
| Total Income - EUR | - | 2.851 | 53.710 | 50.921 | 29.971 | 77.993 | 274.031 | 417.231 | 145.009 | 35.248 |
| Total Expenses - EUR | - | 5.053 | 46.519 | 30.115 | 26.485 | 52.870 | 167.367 | 241.600 | 101.684 | 32.690 |
| Gross Profit/Loss - EUR | - | -2.201 | 7.191 | 20.806 | 3.486 | 25.124 | 106.663 | 175.632 | 43.326 | 2.558 |
| Net Profit/Loss - EUR | - | -2.287 | 5.620 | 20.267 | 3.095 | 24.411 | 103.989 | 171.903 | 42.252 | 956 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Bio-Etalon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 95 | 71 | 47 | 24 | 419 | 255 | 102 | 1.106 | 1.100 |
| Current Assets | - | 14.270 | 30.783 | 89.540 | 105.385 | 132.360 | 161.918 | 352.843 | 256.744 | 288.840 |
| Inventories | - | 13.209 | 19.088 | 39.849 | 83.412 | 77.896 | 37.274 | 145.652 | 89.992 | 122.393 |
| Receivables | - | 901 | 9.969 | 48.536 | 14.034 | 17.142 | 56.737 | 152.706 | 164.086 | 160.153 |
| Cash | - | 160 | 1.726 | 1.155 | 7.938 | 37.322 | 67.907 | 54.485 | 2.666 | 6.294 |
| Shareholders Funds | - | -1.174 | 5.561 | 25.726 | 28.323 | 52.198 | 126.196 | 199.163 | 203.389 | 193.156 |
| Social Capital | - | 1.113 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | 15.539 | 25.292 | 63.860 | 77.085 | 80.581 | 35.978 | 153.782 | 54.462 | 99.487 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4675 - 4675" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Bio-Etalon Srl